4N1K-peptide derived from thrombospondins acts as a tumour suppressor in bladder cancer in vivo and in vitro: Potential therapeutic agents for intra-vesical therapy

4N1K-peptide derived from thrombospondins acts as a tumour suppressor in bladder cancer in vivo and in vitro: Potential therapeutic agents for intra-vesical therapy

Y Miyata, A Asai, T Yasuda, Y Nakamura… - European Urology …, 2018 - Elsevier

458 4N1K-peptide derived from thrombospondins acts as a tumour suppressor in bladder
cancer in vivo and in vitro: Potential therapeutic agents for intra-vesical therapy Eur Urol
Suppl 2018; 17 (2); e656 Mivata Y., Asai A., Yasuda T., Nakamura Y., Sagara Y., Matsuo T …

For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:

*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.

*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.

*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.

*Peptide Salt: TFA, Desalt, Acetate, HCl.

*Peptide Purity: From crude to ＞99.5%.

*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.

*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Quick Links:

Peptide Price
Peptide Modification
Peptide Library
Quote Request
Contact Us

Contact Information:

Eva He
eva@pepmic.com

Pepmic Co., Ltd
www.pepmic.com